thiophenes has been researched along with olanzapine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| Mitchell, CA; Ward, MD; Yu, L | 1 |
| Benvenga, MJ; Bymaster, FP; Calligaro, DO; Cohen, IR; Falcone, JF; Hemrick-Luecke, SK; Martin, FM; Moore, NA; Nelson, DL; Nisenbaum, LK; Rasmussen, K; Schaus, JM; Sundquist, SJ; Tupper, DE; Wiernicki, TR | 1 |
| Kozian, R | 1 |
| Das, A; Desarkar, P; Sinha, VK | 1 |
| Hanretta, AT; Malek-Ahmadi, P | 1 |
| Bercu, JP; Fiori, JM; Meyerhoff, RD; Parke, NJ | 1 |
| Bourgeois, JA; Davidson, CM; Harlow, MC | 1 |
| D'Arrigo, C; Micò, U; Muscatello, MR; Santoro, V; Spina, E; Zoccali, R | 1 |
| Boeker, H; Himmighoffen, H; Seifritz, E | 1 |
| Baulard, A; Bonnel, D; Deprez, B; Hamm, G; Legouffe, R; Stauber, J; Willand, N | 1 |
| Chen, M; Han, H; Huang, Z; Wang, J; Zhang, J; Zhang, Y; Zhong, Z | 1 |
| Kanaya, Y; Kono, R; Kuriyama, M; Shiga, Y; Shimoe, Y; Takeshima, S | 1 |
| Aigbogun, MS; Duffy, R; Hartry, A; Kamat, SA; Legacy, S; Sussman, M; Yu, J | 1 |
| Ashworth, KE; Bush, ND; Halm, MK; Kemp, BE; Medak, KD; Shamshoum, H; Townsend, LK; Wright, DC | 1 |
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Broder, MS; Chang, E; Greene, M; Houle, CR; Tarbox, MH; Waters, HC; Yan, T | 1 |
| Deng, C; Lian, J | 1 |
| Deng, C; Han, M; Lian, J; Su, Y | 1 |
| De Ponti, F; Fusaroli, M; Giunchi, V; Menchetti, M; Poluzzi, E; Raschi, E; Rimondini Giorgini, R | 1 |
2 review(s) available for thiophenes and olanzapine
| Article | Year |
|---|---|
Psychogenic tremor in a patient with a major depressive episode.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cognitive Behavioral Therapy; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Hospitalization; Humans; Olanzapine; Psychophysiologic Disorders; Thiophenes; Tremor | 2009 |
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
17 other study(ies) available for thiophenes and olanzapine
| Article | Year |
|---|---|
Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrates.
Topics: Benzodiazepines; Crystallization; Models, Chemical; Olanzapine; Pimelic Acids; Pirenzepine; Substrate Specificity; Succinic Acid; Thiophenes | 2001 |
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Catalepsy; Cocaine; Corticosterone; Drug Evaluation, Preclinical; Electrochemistry; Electrophysiology; Fasting; Female; Immunohistochemistry; Male; Molecular Structure; Motor Activity; Nucleus Accumbens; Olanzapine; Piperazines; Prolactin; Quipazine; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Histamine H1; Serotonin Receptor Agonists; Thiophenes; Time Factors | 2005 |
[Brief case report. Duloxetine in Cotard syndrome].
Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Citalopram; Delusions; Depersonalization; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Long-Term Care; Olanzapine; Risperidone; Syndrome; Thiophenes | 2005 |
Duloxetine for childhood depression with pain and dissociative symptoms.
Topics: Antidepressive Agents; Benzodiazepines; Child; Depressive Disorder, Major; Dissociative Disorders; Duloxetine Hydrochloride; Female; Humans; Olanzapine; Pain; Thiophenes | 2006 |
Combined use of ECT with duloxetine and olanzapine: a case report.
Topics: Adult; Benzodiazepines; Combined Modality Therapy; Depressive Disorder, Major; Duloxetine Hydrochloride; Electroconvulsive Therapy; Female; Humans; Olanzapine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Thiophenes | 2006 |
Human health risk assessments for three neuropharmaceutical compounds in surface waters.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Benzodiazepines; Drug Residues; Duloxetine Hydrochloride; Environmental Exposure; Fishes; Food Analysis; Forecasting; Humans; Models, Statistical; No-Observed-Adverse-Effect Level; Olanzapine; Propylamines; Risk Assessment; Thiophenes; United States; Water Pollutants, Chemical; Water Supply | 2008 |
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olanzapine, and risperidone in patients with psychotic disorders.
Topics: Adult; Benzodiazepines; Clozapine; Drug Interactions; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Thiophenes; Young Adult | 2010 |
Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.
Topics: Benzodiazepines; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Olanzapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Thiophenes | 2011 |
MALDI imaging techniques dedicated to drug-distribution studies.
Topics: Animals; Benzodiazepines; Mice; Olanzapine; Oxadiazoles; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry; Thiophenes; Tissue Distribution | 2011 |
Effects of low-dose olanzapine on duloxetine-related nausea and vomiting for the treatment of major depressive disorder.
Topics: Adolescent; Adult; Antidepressive Agents; Antiemetics; Benzodiazepines; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Nausea; Olanzapine; Thiophenes; Treatment Outcome; Vomiting; Young Adult | 2014 |
Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: A case report.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bites and Stings; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indoles; Laryngeal Diseases; Levodopa; Lewy Body Disease; Middle Aged; Olanzapine; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes; Tongue Diseases | 2016 |
Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Depressive Disorder, Major; Disorders of Excessive Somnolence; Drug Costs; Drug Therapy, Combination; Fatigue; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Olanzapine; Patient Selection; Quetiapine Fumarate; Quinolones; Serotonin Agents; Thiophenes; Weight Gain; Young Adult | 2017 |
AMPK β1 activation suppresses antipsychotic-induced hyperglycemia in mice.
Topics: AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Biphenyl Compounds; Blood Glucose; Female; Gene Deletion; Gene Expression Regulation, Enzymologic; Glucose Tolerance Test; Hyperglycemia; Mice; Olanzapine; Pyrones; Pyruvic Acid; Thiophenes | 2019 |
Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Care Costs; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Medicaid; Medicare; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Thiophenes; United States | 2020 |
The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats.
Topics: Adipose Tissue; Adiposity; Animals; Behavior, Animal; Blood Glucose; Dose-Response Relationship, Drug; Drug Interactions; Eating; Female; Locomotion; Metabolic Syndrome; Olanzapine; Open Field Test; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Thiophenes; Treatment Outcome; Triglycerides; Weight Gain | 2020 |
Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats.
Topics: AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Female; Liver; Metabolic Diseases; Muscarinic Agonists; Olanzapine; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Signal Transduction; Thiophenes; Weight Gain | 2022 |
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
Topics: Antipsychotic Agents; Aripiprazole; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agonists; Humans; Hyperphagia; Lurasidone Hydrochloride; Olanzapine; Pharmacovigilance; Quinolones; Receptors, Serotonin; Thiophenes; United States; United States Food and Drug Administration | 2022 |